In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...

Chronic HBV kills around 900,000 people every year, said GSK. The company's head of development, Chris Corsico, said that bepirovirsen has the potential to become a "transformative" therapy for ...

Legal-Bay LLC, the premier Pre Settlement Funding Company, reports that the ongoing legal disputes against UK pharmaceutical company GlaxoSmithKline (GSK) regarding their heartburn medicine, Zantac, ...

"The rationale for an ongoing investment in the consumer business will need to be explained by the executives," commented Chris ... for the pharma business that can be reinvested into GSK's ...

Veeva Systems today announced that leaders from Almirall, AstraZeneca, Bayer AG, BioNTech SE, Glenmark, and GSK will be among speakers at Veeva Commercial Summit, Europe on November 19-21 in Madrid, ...

At this time, I would like to welcome everyone to the Biogen third quarter 2024 earnings call and business update. [Operator ...

Biogen's Q3 earnings report shows flat growth but highlights its value for risk-tolerant investors in CNS disease treatment.

Chris Beauchamp, chief market analyst at IG ... down 928p to 10,114p, Hikma Pharmaceuticals, down 36p to 1,820p, GSK, down 22 ...

FIRMS big and small have slammed the Chancellor for saddling them with extra costs in her Budget. They say Rachel Reeves’ ...

Robert F. Kennedy Jr is known as a persistent critic of vaccine safety and is a longtime antagonist of the Food and Drug ...

He then served as CEO of Reliant Pharmaceuticals, helping lead the company to its acquisition by GlaxoSmithKline in 2007 ... loved and respected by his surviving family: three sons, Christopher Mario ...

He then served as CEO to Reliant Pharmaceuticals in Liberty Corner, NJ, helping lead the company to its acquisition by GlaxoSmithKline ... leave behind three sons, Christopher Mario, Greg Mario ...